Drug Trial Radar · NCT00156897
Efficacy and Safety of ATL-962 in Obese Diabetics
Last checked: Nov 20, 2026Latest source record: Aug 29, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Dec 2004
Primary completion
Not stated
Study completion Oct 2005
Sponsor
- Lead sponsor
- AlizymeIndustry
- Sponsor type
- Industry
- First posted
- Sep 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether ATL-962 induces weight loss in diabetic patients and whether its safety and tolerability profile is superior to that of orlistat in such patients
Conditions
- Non-Insulin-Dependent Diabetes Mellitus
- Obesity
Interventions
ATL-962Drug
OrlistatDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute weight loss compared to baseline
Locations
37 sites in 5 countries. Site status is shown where the registry gives one.
Aalborg Sygehus Nord
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
Bispebjerg Hospital
Copenhagen, Denmark
Gentofte Hospital
Hellerup, Denmark
Hvidovre Hospital
Hvidovre, Denmark
Odense University Hospital
Odense, Denmark
Lääkärikeskus Minerva
Eura, Finland
Obesity Research Unit
Helsinki, Finland
Suomen Terveystalo
Jyväskylä, Finland
Oy Foodfiles Limited
Kuopio, Finland
Oulun Diakonissalaitos
Oulu, Finland
University of Oulu
Oulu, Finland
Turku University Hospital
Turku, Finland
Allevon
Den Bosch Ziekenhuis, Netherlands
Allevon
DN de Bilt, Netherlands
Zeikenhuisgroep Twente
Hengelo, Netherlands
Nederlandse Obesitas Klinik
Hilversum, Netherlands
Sint Franciscus Gasthuis
Rotterdam, Netherlands
Sahlgrenska University Hospital
Gothenburg, Sweden
Linkoping University Hospital
Linköping, Sweden
Karolinsaka University Hospital
Stockholm, Sweden
Norrlands Universitetssjukhus
Umeå, Sweden
Samariterhemmets Sjukhus
Uppsala, Sweden
Aberdeen Royal Infirmary
Aberdeen, United Kingdom
Royal United Hospital
Bath, United Kingdom
Clinical Research Centre Edgbaston
Birmingham, United Kingdom
Walsgrave Hospital
Coventry, United Kingdom
Glasgow Royal Infirmary
Glasgow, United Kingdom
Clinical Research Centre, Crosby
Liverpool, United Kingdom
Liverpool University Hospital
Liverpool, United Kingdom
Queen Mary's School of Medicine & Dentistry
London, United Kingdom
Hammersmith Hospital
London, United Kingdom
Luton & Dunstable Hospital
Luton, United Kingdom
Clinical Research Centre
Manchester, United Kingdom
James Cook University Hospital
Middlesbrough, United Kingdom
Royal Shrewsbury Hospital
Shrewsbury, United Kingdom
Clinical Research Centre
Wigan, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.